Results of a prospective, randomized, controlled trial indicate that allopurinol lowers serum uric acid levels and reduces the rate of renal degeneration in patients with mild to moderate chronic ...
XORTX to focus on late stage allopurinol intolerant gout program; discussion with FDA planned for first half 2025 regarding ...
although the regulator has required a black box warning highlighting risk of kidney failure. A once-daily drug, Duzallo combines the standard of care treatment, allopurinol, with Ironwood’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback